Merck MISP Immuno-oncology Grant - Merck

Deadline Date: 
June, 2018

The Investigator Studies Program aims to advance science and improve patient care by supporting, through the provision of drug/vaccine and/or total/partial funding, high-quality research that is initiated, designed, implemented and sponsored by external investigators. Results will be generated and properly disseminated in peer-reviewed publications.

For more information, please visit: http://engagezone.msd.com/oncology.php